OncoSil Medical LtdASX: OSL

Appointment of Chief Executive Officer

· Issued by OncoSil Medical Ltd

Filed with ASX · · 3 pages · English

Sydney, Australia – 21 January 2021: The Board of OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company) is pleased to announce that Mr Nigel Lange has been appointed as Chief Executive Officer and Managing Director of the Company, effective 21 January 2021. Nigel joined the Company in May 2020 as EMEA President, bringing with him over 30 years of experience in the medical devices industry. Since

OncoSil Medical Ltd on 6ix

Story so far

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases